Related Experiment Video
Updated: May 3, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression
Caroline C Huard1, Cédric S Tremblay, Audrey Magron
1Centre Hospitalier Université Laval Research Center, Québec, QC, Canada G1V 4G2 and Departments of Psychiatry and Neurosciences and Pediatrics, Université Laval, Québec, QC, Canada G1V 0A6.
Abstract:
Fanconi anemia (FA) is an inherited bone marrow failure syndrome associated with a progressive decline in hematopoietic stem cells, developmental defects, and predisposition to cancer. These various phenotypic features imply a role of FA proteins in molecular events regulating cellular homeostasis. Interestingly, we previously found that the Fanconi C protein (FANCC) interacts with the C-terminal-binding protein-1 (CtBP1) involved in transcriptional regulation. Here we report that FANCC with CtBP1 forms a complex with β-catenin, and that β-catenin activation through glycogen synthase kinase 3β inhibition leads to FANCC nuclear accumulation and FA pathway activation, as measured by the Fanconi D2 protein (FANCD2) monoubiquitination. β-catenin and FANCC nuclear entry is defective in FA mutant cells and in cells depleted of the Fanconi A protein or FANCD2, suggesting that integrity of the FA pathway is required for FANCC nuclear activity. We also report that FANCC with CtBP1 acts as a negative regulator of Dickkopf-1 (DKK1) expression, and that a FA disease-causing mutation in FANCC abrogates this function. Our findings reveal that a defective FA pathway leads to up-regulation of DKK1, a molecule involved in hematopoietic malignancies.
Insights
Fanconi anemia (FA) pathway proteins regulate cellular homeostasis by interacting with β-catenin. Defects in this pathway lead to increased Dickkopf-1 (DKK1), a molecule implicated in blood cancers.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Biology
Background:
- Fanconi anemia (FA) is an inherited disorder affecting hematopoietic stem cells, leading to bone marrow failure, developmental issues, and cancer predisposition.
- FA proteins are crucial for maintaining cellular homeostasis, with Fanconi C protein (FANCC) previously shown to interact with CtBP1.
- The interaction between FANCC and CtBP1 suggests a role in transcriptional regulation and cellular processes.
Purpose of the Study:
- To investigate the interaction of FANCC-CtBP1 complex with β-catenin.
- To determine the effect of β-catenin activation on the Fanconi anemia pathway.
- To elucidate the role of the FA pathway in regulating Dickkopf-1 (DKK1) expression.
Main Methods:
- Co-immunoprecipitation to identify protein complexes.
- Western blotting to detect protein modifications like FANCD2 monoubiquitination.
- Analysis of nuclear accumulation of proteins via cellular fractionation and imaging.
- Gene expression analysis to quantify DKK1 levels.
Main Results:
- FANCC and CtBP1 form a complex with β-catenin.
- Activation of β-catenin promotes FANCC nuclear entry and FA pathway activation (FANCD2 monoubiquitination).
- Nuclear entry of β-catenin and FANCC is impaired in FA mutant cells, indicating FA pathway integrity is necessary.
- FANCC-CtBP1 complex negatively regulates DKK1 expression; a FA-causing mutation in FANCC abolishes this function.
- Defective FA pathway results in elevated DKK1 levels, linked to hematopoietic malignancies.
Conclusions:
- The Fanconi anemia pathway, through FANCC, interacts with the β-catenin pathway to regulate cellular processes.
- Dysregulation of the FA pathway leads to increased DKK1 expression, contributing to hematopoietic malignancies.
- Targeting the FA-β-catenin-DKK1 axis may offer therapeutic strategies for Fanconi anemia and related cancers.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Co-activators and Co-repressors
Co-activators and Co-repressors
Master Transcription Regulators
Non-Canonical Wnt Signaling Pathways

